Viridian Therapeutics VRDN
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 21.58 | 117.57 | -0.34 | -40,013 | -35 | |
| 2025Q2 | 13.98 | -1.00 | -106,767 | -101 | ||
| 2025Q1 | 13.48 | 108.73 | -0.87 | -93,866 | -87 | |
| 2024Q4 | 19.17 | 110.91 | -0.09 | -87,472 | -80 | |
| 2024Q3 | 22.75 | 110.30 | -1.16 | -83,480 | -77 | |
| 2024Q2 | 13.01 | 112.10 | -1.23 | -72,186 | -65 | |
| 2024Q1 | 17.51 | 116.56 | -0.59 | -55,897 | -49 | |
| 2023Q4 | 21.78 | 108.39 | 0.06 | -71,478 | -67 | |
| 2023Q3 | 15.34 | 108.85 | -1.09 | -51,224 | -48 | |
| 2023Q2 | 23.79 | 107.97 | -1.27 | -59,275 | -55 | |
| 2023Q1 | 25.44 | 106.60 | -1.61 | -72,473 | -68 | |
| 2022Q4 | 29.21 | 107.56 | 0.17 | -49,066 | -46 | |
| 2022Q3 | 20.51 | 103.63 | -0.83 | -29,785 | -29 | |
| 2022Q2 | 11.57 | 100.77 | -1.07 | -29,564 | -29 | |
| 2022Q1 | 18.49 | 100.76 | -0.98 | -25,889 | -26 | |
| 2021Q4 | 19.77 | 100.48 | -0.71 | -29,081 | -29 | |
| 2021Q3 | 16.45 | 100.65 | -0.91 | -14,134 | -14 | |
| 2021Q2 | 18.29 | 100.19 | -2.13 | -17,998 | -18 | |
| 2021Q1 | 16.71 | 100.30 | -2.91 | -18,515 | -18 | |
| 2020Q4 | 16.45 | 100.04 | -25.31 | -90,598 | -91 |